Summary
As lentiviral vectors (LVV) are increasingly used for in vivo and ex vivo gene delivery in the creation of therapies for common genetic and acquired diseases, large-scale biomanufacturing of clinical-grade LVV products must meet strict manufacturing, product characterization, and regulatory requirements.
Learn how Simple Western™ makes lentiviral vector analysis for cell and gene therapy simple, with multi-attribute CQA characterization in a platform approach, including:
- Identity
- Titer
- Stability
- Empty/full capsid content ratio
- Purity
- Transduction analysis
Request Literature
To access this literature content please fill out the form below.